Published on:

Trial lawyers protest warning-label rule

A proposed federal rule would grant immunity from product liability lawsuits to drug and medical device makers that do not warn about their products’ dangerous side effects. This has drawn objections from trial lawyers. The American Association for Justice (AAJ) believes that the FDA must revise its preamble to eliminate any reference to the pre-emption of product liability lawsuits.

For the full article.